Certificate number:RU.77.99.32.003.Е.004625.10.17 Date of registration and renewal:31.10.2017 Dosage form: & nbspCapsules weighing 496 mg. Classification "Composition" & nbsp Supplements - probiotics and prebiotics Classification "Clinical" & nbsp Supplements that support the functions of the digestive system BAA, improving digestion and functional state of the digestive tract Supplements supporting motor-evacuation function of the intestine Supplements promoting normalization and maintenance of normal intestinal microflora Supplements that affect the process of detoxification and promote the elimination of foreign and toxic substances from the body Composition: & nbspBifidobacterium bifidum HA-132, Bifidobacterium longum HA-135, Bifidobacterium breve YA-129, Lactobacillus acidophilus HA-122, Lactobacillus casei HA-108, Lactobacillus plantarum HA-119, Lactobacillus rhamnosus HA-111, MCC, E171. Scope: & nbspFor sale to the population through the pharmacy network and specialized shops, departments of the trade network as a biologically active food additive - a source of probiotic microorganisms (bifidobacteria, lactobacilli). Suggested Usage: & nbspAdults take 1 capsule 1 time per day during meals. Duration of admission is 1 month. Contraindications:Individual intolerance of components. Special instructions:Before use, it is recommended to consult a doctor. Shelf life:24 months. Storage conditions:Store in a dry place at room temperature. Research protocols:In exchange for the certificate of state registration No. RU.77.99.32.003.Е.003474.02.15 of 13.02.2015, expert opinions of the FGBICU "NII Nutrition" №72 / Э-1377 / б-14 of 27.11.2014,FGBUN "FIC of Power and Biotechnology" No. 529 / E-804 / b-17 of September 28, 2017. ManufacturersPRIMEA LIMITED United KingdomPRIMEA LIMITED, 147-157 John Street, EC 1V 4PY, London (United Kingdom). Recipient:Novator Pharma, LLCNovator Pharma, LLC Russian Federation Information update date: & nbsp17.01.2018 Instructions